SKB500 Combinations in Patients With Small Cell Lung Cancer

NCT07296809 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: SKB500 Powder for Injection
DRUG: KL-A167 Injection
DRUG: Carboplatin Injection
DRUG: Etoposide Injection

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.